Podcast: This Week in Managed Care—Gottlieb Discusses Out-of-Pocket Drug Costs and Other Health News

July 28, 2019

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included bipartisan Senate bills taking aim at drug prices, especially insulin; a study linking payer refusal to pay for proprotein convertase subtilisin/kexin type 9 inhibitors with heart attacks and deaths; and a former FDA commissioner visiting The American Journal of Managed Care®.

iTunes

TuneIn

Stitcher

Spotify

Listen above or through one of these podcast services:

Senate Finance Committee Unveils Bipartisan Bill to Lower Drug Costs

Bipartisan Senate Bill Seeks to Roll Back a Decade's Worth of Insulin Price Hikes

Rejected, Unfilled PCSK9 Inhibitor Prescriptions Linked to Higher Risk of Cardiovascular Events

Impact of a Co-pay Accumulator Adjustment Program on Specialty Drug Adherence

Consuming Riboflavin Through Diet May Reduce Migraine Occurrence

Read more about the stories in this podcast: